|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 65.56 USD | +0.55% |
|
+2.74% | +5.74% |
| Apr. 18 | B. Riley Raises Price Target on Lantheus Holdings to $99 From $95, Keeps Buy Rating | MT |
| Mar. 07 | Lantheus Holdings Insider Sold Shares Worth $262,005, According to a Recent SEC Filing | MT |
On March 6, 2024, Perspective Therapeutics, Inc. closed the transaction. The company will issue securities pursuant to exemption provided under Regulation D from 9 investors.
Price
|
Change
|
5d. change
|
Capi.
| ||
|---|---|---|---|---|---|
| 65.56 USD | +0.55% | +2.74% | 4.49B | ||
| 1.58 USD | -1.25% | +5.33% | 927M | ||
| 1st Jan change | Capi. | |
|---|---|---|
| +5.74% | 4.49B | |
| +0.89% | 12.8B | |
| -10.29% | 7.61B | |
| +1.78% | 5.41B | |
| -1.16% | 4.51B | |
| -50.70% | 3.29B | |
| +12.21% | 2.73B | |
| -16.13% | 2.02B | |
| -11.50% | 1.73B | |
| -5.02% | 1.64B |
LANTHEUS HOLDINGS, INC. 
